The Pennant Group (PNTG)
(Delayed Data from NSDQ)
$34.79 USD
+1.00 (2.96%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $34.78 -0.01 (-0.03%) 6:30 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.79 USD
+1.00 (2.96%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $34.78 -0.01 (-0.03%) 6:30 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Zacks News
PNTG or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
Are Investors Undervaluing The Pennant Group (PNTG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PNTG vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
The Pennant Group, Inc. (PNTG) Q3 Earnings Lag Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -22.22% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PNTG vs. CHE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
Wall Street Analysts Believe The Pennant Group, Inc. (PNTG) Could Rally 44%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 43.5% upside potential for The Pennant Group, Inc. (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Pennant Group, Inc. (PNTG) Meets Q2 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 2.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Addus HomeCare (ADUS) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 1.11% and 1.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) Stock Jumps 6%: Will It Continue to Soar?
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Is the Options Market Predicting a Spike in The Pennant Group (PNTG) Stock?
by Zacks Equity Research
Investors need to pay close attention to The Pennant Group (PNTG) stock based on the movements in the options market lately.
Why The Pennant Group, Inc. (PNTG) Might be Well Poised for a Surge
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does The Pennant Group, Inc. (PNTG) Have the Potential to Rally 29% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 29.4% upside potential for The Pennant Group, Inc. (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 37.50% and 4.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Oak Street Health, Inc. (OSH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of -10.26% and 1.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Addus HomeCare (ADUS) Tops Q1 Earnings Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 1.32% and 0.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) to Spin Off Home Health & Hospice Unit
by Zacks Equity Research
Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.
The Pennant Group, Inc. (PNTG) Matches Q3 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0.00% and 0.78%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Pennant Group, Inc. (PNTG) Misses Q2 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -10.53% and 2.65%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate The Pennant Group, Inc. (PNTG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for June 23rd
by Zacks Equity Research
PNTG, GHLD, EXPI, ACR and AG have been added to the Zacks Rank #5 (Strong Sell) List on June 23, 2021.
The Pennant Group (PNTG) is in Overbought Territory: What's Next?
by Zacks Equity Research
The Pennant Group (PNTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company
The Pennant Group, Inc. (PNTG) Q1 Earnings Miss Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -38.89% and 1.31%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Can The Pennant Group, Inc. (PNTG) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
3 Top Outpatient and Home Healthcare Stocks to Watch Out For
by Trina Mukherjee
Despite the challenges thrown by the COVID-19 pandemic, rising dependence on telehealth and AI's dominant role should drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, USPH and PNTG are well positioned to gain from the prospects.